Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/96037
標題: Anti-coxsackievirus B3 activity and relevant mechanisms of glycyrol in Vero cells
甘草醇對腸病毒克沙奇B3型於非洲綠猴腎細胞之抑制及相關作用機轉
作者: Hsin-I Chou
周欣儀
關鍵字: 腸病毒克沙奇B3型
甘草醇
作用機轉
coxsackievirus B3
glycyrol
mechanisms
引用: 李侑真。(2009)。台灣克沙奇病毒之分子流行病學與中樞神經感染之分子影像分析診斷。高雄醫學大學。 林翠莉, 陳國東, 王恩慈, 李宜學, 黃教威, 徐秋菊, & 吳和生。(2007)。1998~2006年台灣地區腸病毒重症個案血清型之分析探討與警愓。 曾士展。(2003)。IRES序列的應用與開發。國立嘉義大學生物科技研究所,碩士論文,嘉義。 楊心宜。(2014)。七葉一枝花抗腸病毒 71 型活性成分之分離純化及作用機轉。(碩士論文)。國立中興大學食品暨應用生物科技學系,碩士論文,臺中。 劉武哲。(2002)。臨床病毒學檢驗手冊。藝軒圖書出版社,台北。 蔡明勳。(2009)。克沙奇 B3 病毒感染 Huh7 細胞影響細胞受體的表現。國立成功大學微生物及免疫學研究所,碩士論文,臺南。 衛生福利部疾病管制署。(2013)。傳染病統計暨監視年報:衛生福利部疾病管制署。 衛生福利部疾病管制署。(2016)。新生兒腸病毒臨床處置建議 (pp. 1-28): 衛生福利部疾病管制署。 Adianti, M., Aoki, C., Komoto, M., Deng, L., Shoji, I., Wahyuni, T. S., Lusida, M. I., Soetjipto, Fuchino, H., Kawahara, N., & Hotta, H. (2014). Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species. Microbiology and Immunology, 58 (3), 180-187. Aramburu, J., Rao, A., & Klee, C. B. (2001). Calcineurin: from structure to function. Current Topics in Cellular Regulation, 36, 237-295. Beltrami, C. A., Finato, N., Rocco, M., Feruglio, G. A., Puricelli, C., Cigola, E., Sonnenblick, E. H., Olivetti, G., & Anversa, P. (1995). The cellular basis of dilated cardiomyopathy in humans. Journal of Molecular and Cellular Cardiology, 27 (1), 291-305. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997). Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5. Science, 275 (5304), 1320-1323. Buenz, E. J., & Howe, C. L. (2006). Picornaviruses and cell death. Trends in Microbiology, 14 (1), 28-36. Cen, J., Shi, M., Yang, Y., Fu, Y., Zhou, H., Wang, M., Su, Z., & Wei, Q. (2013). Isogarcinol is a new immunosuppressant. PloS one, 8 (6), e66503. Chang, L., & Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature, 410 (6824), 37-40. Chang, L. Y. (2008). Enterovirus 71 in Taiwan. Pediatrics & Neonatology, 49(4), 103-112. Chen, J. W., Zhou, B., Yu, Q. C., Shin, S. J., Jiao, K., Schneider, M. D., Baldwin, H. S., & Bergelson, J. M. (2006). Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circulation Research, 98 (7), 923-930. Choi, H., Lim, C., Song, J., Baek, S., & Kwon, D. (2009). Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine, 16 (1), 35-39. Chu, P. Y., Ke, G. M., Chen, Y. S., Lu, P. L., Chen, H. L., Lee, M. S., B. C. Chen., T. S. Huang., Y. C. Li., L. C. Chou., S. Y. Wang., & Lin, K. H. (2010). Molecular epidemiology of Coxsackievirus B3. Infection, Genetics and Evolution, 10 (6), 777-784. Chung, S. K., Kim, J. Y., Kim, I. B., Park, S. I., Paek, K. H., & Nam, J. H. (2005). Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology, 333 (1), 31-40. Coyne, C. B., & Bergelson, J. M. (2006). Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell, 124 (1), 119-131. Crowell, R. L., & Landau, B. J. (1997). A short history and introductory background on the coxsackieviruses of group B The Coxsackie B Viruses (pp. 1-11): Springer. Dalldorf, G. (1950). The coxsackie viruses. American Journal of Public Health and the Nations Health, 40 (12), 1508-1511. Dalldorf, G., & Sickles, G. M. (1948). An unidentified, filtrable agent isolated from the feces of children with paralysis. Science (Washington), 61-64. Das, S., & Dasgupta, A. (1993). Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. Journal of Virology, 67 (6), 3326-3331. Deng, Y. P., Liu, Y. Y., Liu, Z., Li, J., Zhao, L. M., Xiao, H., Ding, X. H., & Yang, Z. Q. (2013). Antiviral activity of Folium isatidis derived extracts in vitro and in vivo. The American Journal of Chinese Medicine, 41 (04), 957-969. English, J., Pearson, G., Wilsbacher, J., Swantek, J., Karandikar, M., Xu, S., & Cobb, M. H. (1999). New insights into the control of MAP kinase pathways. Experimental Cell Research, 253 (1), 255-270. Epelman, S., Liu, P. P., & Mann, D. L. (2015). Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nature Reviews Immunology, 15 (2), 117-129. Esfandiarei, M., & McManus, B. M. (2008). Molecular biology and pathogenesis of viral myocarditis. Annual Review of Pathology Mechanisms of Disease, 3, 127-155. Fan, X., Yue, Y., & Xiong, S. (2017). Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis. Antiviral Research, 140, 121-132. Fields, B. N., Knipe, D. M., & Howley, P. M. (1996). Fields Virology (Vol. 1). USA: Lippincott-Raven Publishers. Fu, Y., Zhou, H., Wang, S., & Wei, Q. (2014). Glycyrol suppresses collagen-induced arthritis by regulating autoimmune and inflammatory responses. PloS one, 9 (7), e98137. Garmaroudi, F. S. (2011). Intracellular signaling networks regulate host-cell responses to coxsackievirus B3 infection. University of British Columbia. Garmaroudi, F. S., Marchant, D., Hendry, R., Luo, H., Yang, D., Ye, X., Shi, J., & McManus, B. M. (2015). Coxsackievirus B3 replication and pathogenesis. Future Microbiology, 10 (4), 629-653. Ge, M., Wang, H., Zhang, G., Yu, S., & Li, Y. (2014). The antiviral effect of jiadifenoic acids C against coxsackievirus B3. Acta Pharmaceutica Sinica B, 4 (4), 277-283. Genovese, D., Conti, C., Tomao, P., Desideri, N., Stein, M. L., Catone, S., & Fiore, L. (1995). Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Research, 27 (1-2), 123-136. Ghosh, S., & Hayden, M. S. (2008). New regulators of NF-κB in inflammation. Nature Reviews Immunology, 8(11), 837-848. Ghosh, S., & Karin, M. (2002). Missing pieces in the NF-κB puzzle. Cell, 109 (2), S81-S96. Gilbert, B. E., & Knight, V. (1986). Biochemistry and clinical applications of ribavirin. Antimicrobial Agents and Chemotherapy, 30 (2), 201. Gorbalenya, A. E., Blinov, V. M., & Donchenko, A. P. (1986). Poliovirus-encoded proteinase 3C: a possible evolutionary link between cellular serine and cysteine proteinase families. FEBS Letters, 194 (2), 253-257. Greber, U. F., & Gastaldelli, M. (2007). Junctional gating: the achilles' heel of epithelial cells in pathogen infection. Cell Host & Microbe, 2 (3), 143-146. Guo, D., Zhu, Q., Zhang, H., & Sun, D. (2014). Proteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry. DNA and Cell Biology, 33 (1), 20-28. Hattori, M., Miyahci, K., Shu, Y. Z., Kakiuchi, N., & Namba, T. (1986). Studies on dental caries prevention by traditional medicines (IX): potent antibacterial action of coumarin derivatives from Licorice roots against Streptococcus mutans. The Japanese Society of Pharmacognosy, 40 (4), 406-412. Hayden, M. S., & Ghosh, S. (2008). Shared principles in NF-κB signaling. Cell, 132 (3), 344-362. He, Y., Chipman, P. R., Howitt, J., Bator, C. M., Whitt, M. A., Baker, T. S., Kuhn, R. J., Anderson, C. W., Freimuth, P., & Rossmann, M. G. (2001). Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nature Structural & Molecular Biology, 8 (10), 874-878. Hirasawa, K., Kim, A., Han, H. S., Han, J., Jun, H. S., & Yoon, J. W. (2003). Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus. Journal of Virology, 77 (10), 5649-5656. Holmes, E. C. (2003). Molecular clocks and the puzzle of RNA virus origins. Journal of virology, 77 (7), 3893-3897. Hsiung, G. D., Fong, C. K. Y., & Landry, M. L. (1994). Hsiung's diagnostic virology: as illustrated by light and electron microscopy (Vol. 1): Yale University Press. Huang, X., Li, B., & Shen, L. (2014). Studies on the anti-inflammatory effect and its mechanisms of sophoridine. Journal of Analytical Methods in Chemistry, 2014. Huber, M., Watson, K. A., Selinka, H. C., Carthy, C. M., Klingel, K., McManus, B. M., & Kandolf, R. (1999). Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. Journal of Virology, 73 (5), 3587-3594. Hyöty, H., & Taylor, K. (2002). The role of viruses in human diabetes. Diabetologia, 45 (10), 1353-1361. Ito, M., Kodama, M., Masuko, M., Yamaura, M., Fuse, K., Uesugi, Y., Hirono, S., Y.Okura, Kato, K., & Hotta, Y. (2000). Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circulation Research, 86 (3), 275-280. Ivanoff, L. A., Towatari, T., Ray, J., Korant, B. D., & Petteway, S. R. (1986). Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli. Proceedings of the National Academy of Sciences, 83 (15), 5392-5396. Jin, Y. L., Kim, S., Kim, Y. S., Kim, S. A., & Kim, H. S. (2008). The first total synthesis of glycyrol. Tetrahedron Letters, 49 (48), 6835-6837. Joachims, M., Breugel, P. C. V., & Lloyd, R. E. (1999). Cleavage of poly (A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. Journal of Virology, 73 (1), 718-727. Johnson, G. L., & Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298 (5600), 1911-1912. Johnson, J. C., Martinez, O., Honko, A. N., Hensley, L. E., Olinger, G. G., & Basler, C. F. (2014). Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Research, 107, 102-109. Kim, J. Y., Jeon, E. S., Lim, B. K., Kim, S. M., Chung, S. K., Kim, J. M., Park, S. I., Jo, I., & Nam, J. H. (2005). Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine, 23 (14), 1672-1679. Kim, K. S., Hufnagel, G., Chapman, N. M., & Tracy, S. (2001). The group B coxsackieviruses and myocarditis. Reviews in Medical Virology, 11 (6), 355-368. Kishimoto, C., Crumpacker, C. S., & Abelmann, W. H. (1988). Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. Journal of the American College of Cardiology, 12 (5), 1334-1341. Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., Mall, G., & Kandolf, R. (1992). Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proceedings of the National Academy of Sciences, 89 (1), 314-318. Kondo, L. K., Hourcade, D. E., Anderson, V. E., Muqim, N., Mitchell, L., Soares, D. C., Barlow, P. N., & Medof, M. E. (2007). Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. Journal of Biological Chemistry, 282 (25), 18552-18562. Kotwal, G. J., Hatch, S., & Marshall, W. L. (2012). Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune response. Advances in Virology, 2012, 131457. Kräusslich, H. G., Nicklin, M. J., Toyoda, H., Etchison, D., & Wimmer, E. (1987). Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. Journal of Virology, 61 (9), 2711-2718. Kuppeveld, F. J. M., Melchers, W. J. G., & Gadella, T. W. J. (2002). Homomultimerization of the coxsackievirus 2B protein in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Journal of Virology, 76, 9446-9456. Lee, S. G., Oh, H. M., Lim, W. B., Choi, E. J., Park, Y. N., Kim, J. A., Choi, J. Y., Hong, S. J., Oh, H. K., & Son, J. K. (2008). Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis. Anti-cancer Drugs, 19 (5), 503-515. Lee, S. G., Oh, H. M., Lim, W. B., Choi, E. J., Park, Y. N., Kim, J. A., Choi, J. Y., Hong, S. J., Oh, H. K., & Son, J. K. (2008). Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis. Anti-cancer Drugs, 19 (5), 503-515. Lee, S. T., Ki, C. S., & Lee, N. Y. (2007). Molecular characterization of enteroviruses isolated from patients with aseptic meningitis in Korea, 2005. Archives of Virology, 152 (5), 963-970. Li, J., Y.Tu, Tong, L., Zhang, W., Zheng, J., & Wei, Q. (2010). Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity. Pharmaceutical Biology, 48 (10), 1177-1184. Li, Y., Leung, K. T., Yao, F., Ooi, L. S. M., & Ooi, V. E. C. (2006). Antiviral flavans from the leaves of Pithecellobium clypearia. Journal of Natural Products, 69 (5), 833-835. Liebig, H. D., Seipelt, J., Vassilieva, E., Gradi, A., & Kuechler, E. (2002). A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII. FEBS Letters, 523 (1-3), 53-57. Lim, B. K., Choi, J. H., Nam, J. H., Gil, C. O., Shin, J. O., Yun, S. H., Kim, D. K., & Jeon, E. S. (2006). Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovascular Research, 71 (3), 517-526. Lin, T. L., Chen, K. T., Wang, E. T., Li, Y. S., Huang, C. W., Hsu, C. C., & Wu, H. S. (2007). A serotype analysis of individual cases of severe enterovirus in Taiwan region, 1998~ 2006. Epidemiology Bulletin, 23 (4), 279-280. Liu, F., Wang, Y., Zhu, X., Jin, Y., Chen, Y., Wang, Q. Q., Chang, H., Song, J., & Huang, L. (2010). The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3. Journal of Ethnopharmacology, 127 (2), 221-228. Lublin, D. M., & Atkinson, J. P. (1989). Decay-accelerating factor: biochemistry, molecular biology, and function. Annual Review of Immunology, 7 (1), 35-58. Luo, H., Yanagawa, B., Zhang, J., Luo, Z., Zhang, M., Esfandiarei, M., Carthy, C., J. E. Wilson, Yang, D., & McManus, B. M. (2002). Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. Journal of Virology, 76 (7), 3365-3373. M.Bergelson, J., Krithivas, A., Celi, L., Droguett, G., Horwitz, M. S., Wickham, T., Crowell, R. L., & W.Finberg, R. (1998). The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. Journal of Virology, 72 (1), 415-419. MacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P., & Minor, P. (2004). Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. The Lancet, 363 (9420), 1509-1513. Maekawa, Y., Ouzounian, M., Opavsky, M. A., & Liu, P. P. (2007). Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation, 115 (1), 5-8. Mankan, A. K., Lawless, M. W., Gray, S. G., Kelleher, D., & McManus, R. (2009). NF‐κB regulation: the nuclear response. Journal of Cellular and Molecular Medicine, 13 (4), 631-643. Mann, D. L. (2011). The emerging role of innate immunity in the heart and vascular system. Circulation Research, 108 (9), 1133-1145. Marchant, D., Si, X., Luo, H., McManus, B., & Yang, D. (2008). The impact of CVB3 infection on host cell biology Group B Coxsackieviruses (pp. 177-198): Springer. Martinez, N. M. K., Joachims, M., & Lloyd, R. E. (2002). Efficient cleavage of ribosome-associated poly (A)-binding protein by enterovirus 3C protease. Journal of Virology, 76 (5), 2062-2074. McBride, A. E., Schlegel, A., & Kirkegaard, K. (1996). Human protein Sam68 relocalization and interaction with poliovirus RNA polymerase in infected cells. Proceedings of the National Academy of Sciences, 93 (6), 2296-2301. Moore, M., Kaplan, M. H., McPhee, J., Bregman, D. J., & Klein, S. W. (1984). Epidemiologic, clinical, and laboratory features of coxsackie B1-B5 infections in the United States, 1970-79. Public Health Reports, 99 (5), 515. Muckelbauer, J. K., & Rossmann, M. G. (1997). The structure of coxsackievirus B3 The Coxsackie B Viruses (pp. 191-208): Springer. Muench, H. R. (1938). A simple method of estimating 50 per cent end points. American Journal of Epidemiology, 27, 493-497. Nicholson-Weller, A., Burge, J., & Austen, K. F. (1981). Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b, 2a. The Journal of Immunology, 127 (5), 2035-2039. Nomura, H., Tanimoto, H., Kajiwara, E., Shimono, J., Maruyama, T., Yamashita, N., Nagano, M., Higashi, M., Mukai, T., & Matsui, Y. (2004). Factors contributing to ribavirin‐induced anemia. Journal of Gastroenterology and Hepatology, 19 (11), 1312-1317. Noutsias, M., Fechner, H., Jonge, H. d., Wang, X., Dekkers, D., Houtsmuller, A. B., Pauschinger, M., Bergelson, J., Warraich, R., Yacoub, M., Hetzer, R., Lamers, J., Schultheiss, H. P., & Poller, W. (2001). Human coxsackie-adenovirus receptor is colocalized with integrins αvβ3 and αvβ5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy. Circulation, 104 (3), 275-280. O'Neill, L. A. J., & Kaltschmidt, C. (1997). NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends in Neurosciences, 20 (6), 252-258. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Loreto, C. D., Beltrami, C. A., & Krajewski, S. (1997). Apoptosis in the failing human heart. The New England Journal of Medicine, 336(16), 1131-1141. Ong, K. C., & Wong, K. T. (2015). Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathology, 25(5), 614-624. Ooij, M. J. M. V., Vogt, D. A., Paul, A., Castro, C., Kuijpers, J., Kuppeveld, F. J. M. v., Cameron, C. E., Wimmer, E., Andino, R., & Melchers, W. J. G. (2006). Structural and functional characterization of the coxsackievirus B3 CRE (2C): role of CRE (2C) in negative-and positive-strand RNA synthesis. Journal of General Virology, 87 (1), 103-113. P. Yalamanchili, Harris, K., Wimmer, E., & Dasgupta, A. (1996). Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. Journal of Virology, 70 (5), 2922-2929. Pamonsinlapatham, P., Hadj-Slimane, R., Lepelletier, Y., Allain, B., Toccafondi, M., Garbay, C., & Raynaud, F. (2009). p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling. Biochimie, 91 (3), 320-328. Peng, L., Qi, Y., Wu, H., & Wei, Q. (2011). Interaction of glycyrol with calcineurin a studied by spectroscopic methods and docking. International Union of Biochemistry and Molecular Biology Life, 63 (1), 14-20. Pevear, D. C., Fancher, M. J., Felock, P. J., Rossmann, M. G., Miller, M. S., Diana, G., Treasurywala, A. M., McKinlay, M. A., & Dutko, F. J. (1989). Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. Journal of Virology, 63 (5), 2002-2007. Plotnikov, A., Zehorai, E., Procaccia, S., & Seger, R. (2011). The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochimica et Biophysica Acta Molecular Cell Research, 1813 (9), 1619-1633. Rotbart, H. A. (2002). Treatment of picornavirus infections. Antiviral research, 53(2), 83-98. Rueckert, R. R., & Wimmer, E. (1984). Systematic nomenclature of picornavirus proteins. Journal of Virology, 50 (3), 957. Saitoh, T., & Shibata, S. (1969). Chemical studies on the oriental plant drugs. XXII. Some new constituents of Licorice root.(2) glycyrol, 5-O-methylglycyrol and isoglycyrol. Chemical and Pharmaceutical Bulletin, 17 (4), 729-734. Sawyer, M. H. (2002). Enterovirus infections: diagnosis and treatment. Paper presented at the Seminars in pediatric infectious diseases. Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997). The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science, 277 (5324), 333-339. Schmidtke, M., Hammerschmidt, E., Schüler, S., Zell, R., Birch-Hirschfeld, E., Makarov, V. A., Riabova, O. B., & Wutzler, P. (2005). Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. Journal of Antimicrobial Chemotherapy, 56 (4), 648-656. Schoub, B. D., Johnson, S., McAnerney, J. M., Martin, E., & Santos, I. L. D. (1986). Laboratory studies of the 1984 influenza epidemic on the Witwatersrand. South African Medical Journal, 70 (13), 815-818. Selinka, H. C., Huber, M., Pasch, A., Klingel, K., Aepinus, C., & Kandolf, R. (1998). Coxsackie B virus and its interaction with permissive host cells. Clinical and Diagnostic Virology, 9 (2), 115-123. Shaheen, M., Borsanyiova, M., Mostafa, S., Chawla-Sarkar, M., Bopegamage, S., & El-Esnawy, N. (2015). In vitro effect of Dodonaea viscosa extracts on the replication of coxackievirus B3 (Nancy) and rotavirus (SA-11). Journal of Microbiology and Antimicrobial Agents, 1 (2). Shih, T. Y., Hattori, S., Clanton, D. J., Ulsh, L. S., Chen, Z. Q., Lautenberger, J. A., & Papas, T. S. (1985). Structure and function of p21 ras proteins. Gene Amplification and Analysis, 4, 53-72. Shin, E. M., Zhou, H. Y., Guo, L. Y., Kim, J. A., Lee, S. H., Merfort, I., Kang, S. S., Kim, H. S., Kim, S., & Kim, Y. S. (2008). Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264. 7 macrophages. International Immunopharmacology, 8 (11), 1524-1532. Si, X., Wang, Y., Wong, J., Zhang, J., McManus, B. e. M., & Luo, H. (2007). Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Journal of Virology, 81(7), 3142-3150. Sidwell, R. W., Robins, R. K., & Hillyard, I. W. (1979). Ribavirin: an antiviral agent. Pharmacology & Therapeutics, 6 (1), 123-146. Sin, J., Mangale, V., Thienphrapa, W., Gottlieb, R. A., & Feuer, R. (2015). Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology, 484, 288-304. Sobotta, K., Wilsky, S., Althof, N., Wiesener, N., Wutzler, P., & Henke, A. (2012). Inhibition of nuclear factor kappa B activation reduces Coxsackievirus B3 replication in lymphoid cells. Virus Research, 163 (2), 495-502. Soliman, M. L., Puig, K. L., Combs, C. K., & Rosenberger, T. A. (2012). Acetate reduces microglia inflammatory signaling in vitro. Journal of Neurochemistry, 123 (4), 555-567. Song, J. H., Choi, H. J., Song, H. H., Hong, E. H., Lee, B. R., Oh, S. R., Choi, K., Yeo, S. G., Lee, Y. P., & Cho, S. (2014). Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3. Journal of Ginseng Research, 38 (3), 173-179. Song, J. H., Kwon, B. E., Jang, H., Kang, H., Cho, S., Park, K., Ko, H. J., & Kim, H. (2015). Antiviral Activity of Chrysin Derivatives against Coxsackievirus B3 in vitro and in vivo. Biomolecules & Therapeutics, 23 (5), 465-470. Song, X., Liu, Z., Wang, H., Xin, Y., Wang, X., Chen, J., Shi, Y., Zhang, C., & Hui, R. (2007). QiHong prevents death in coxsackievirus B3–induced murine myocarditis through inhibition of virus attachment and penetration. Experimental Biology and Medicine, 232 (11), 1441-1448. Steil, B. P., & Barton, D. J. (2009a). Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Research, 139 (2), 240-252. Steil, B. P., & Barton, D. J. (2009b). Conversion of VPg into VPgpUpUOH before and during poliovirus negative-strand RNA synthesis. Journal of Virology, 83(24), 12660-12670. Su, M., Li, Y., Leung, K. T., Cen, Y., Li, T., Chen, R., & Ooi, V. E. (2006). Antiviral activity and constituent of Ardisia chinensis benth against coxsackie B3 virus. Phytotherapy Research, 20 (8), 634-639. Szalay, G., Meiners, S., Voigt, A., Lauber, J., Spieth, C., Speer, N., Sauter, M., Kuckelkorn., U., Zell, A., & Klingel, K. (2006). Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. The American Journal of Pathology, 168 (5), 1542-1552. Tanaka, Y., Kikuzaki, H., Fukuda, S., & Nakatani, N. (2001). Antibacterial compounds of licorice against upper airway respiratory tract pathogens. Journal of Nutritional Science and Vitaminology, 47 (3), 270-273. Tao, S., Liang, X. Y., & Wang, Y. (2015). Screening of active compounds with myocardial protective effects from Tongmai Yangxin pill (1008-9292). Tao, Z., Song, Y., Li, Y., Liu, Y., Jiang, P., Lin, X., Liu, G., Song, L., Wang, H., & Xu, A. (2012). Coxsackievirus b3, Shandong province, china, 1990–2010. Emerging Infectious Diseases, 18 (11), 1865. Tracy, S., Chapman, N. M., & Mahy, B. W. J. (2013). The Coxsackie B Viruses (Vol. 223): Springer Science & Business Media. Tracy, S., Oberste, M. S., & Drescher, K. M. (2008). Group B Coxsackieviruses (Vol. 1): Springer. Tseng, F. C., Huang, H. C., Chi, C. Y., Lin, T. L., Liu, C. C., Jian, J. W., Hsu, L. C., Wu, H. S., Yang, J. Y., & Chang, Y. W. (2007). Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. Journal of Medical Virology, 79 (12), 1850-1860. Wang, H., Ding, Y., Zhou, J., Sun, X., & Wang, S. (2009). The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine, 16 (2), 146-155. Wang, L., Yang, R., Yuan, B., Liu, Y., & Liu, C. (2015). The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharmaceutica Sinica B, 5(4), 310-315. Wang, S. M., & Liu, C. C. (2014). Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert review of anti-Infective Therapy, 12 (4), 447-456. Wei, X., Cheng, P., & Feng, W. (2013). Study on the inhibitory effect of anti-respiratory viruses and toxicity of patchouli alcohol in vitro. Pharmacology and Clinics of Chinese Materia Medica, 1, 009. Whitton, J. L. (2002). Immunopathology during coxsackievirus infection. Springer Seminars in Immunopathology, 24 (2), 201-213. Woodruff, J. F. (1980). Viral myocarditis. A review. The American Journal of Pathology, 101 (2), 425. Xin, L., Ma, X., Xiao, Z., Yao, H., & Liu, Z. (2015). Coxsackievirus B3 induces autophagy in HeLa cells via the AMPK/MEK/ERK and Ras/Raf/MEK/ERK signaling pathways. Infection, Genetics and Evolution, 36, 46-54. Xiong, H. R., Shen, Y. Y., Lu, L., Hou, W., Luo, F., Xiao, H., & Yang, Z. Q. (2012). The inhibitory effect of Rheum palmatum against coxsackievirus B3 in vitro and in vivo. The American Journal of Chinese Medicine, 40 (04), 801-812. Xu, M. Y., & Kim, Y. S. (2014). Antitumor activity of glycyrol via induction of cell cycle arrest, apoptosis and defective autophagy. Food and Chemical Toxicology, 74, 311-319. Xu, X., Xie, H., Wang, Y., & Wei, X. (2010). A-type proanthocyanidins from lychee seeds and their antioxidant and antiviral activities. Journal of Agricultural and Food Chemistry, 58 (22), 11667-11672. Yajima, T., & Knowlton, K. U. (2009). Viral myocarditis: from the perspective of the virus. Circulation, 119 (19), 2615-2624. Yen, F. B., Chang, L. Y., Kao, C. L., Lee, P. I., Chen, C. M., Lee, C. Y., Shao, P. L., Wang, S. C., Lu, C. Y., & Huang, L. M. (2009). Coxsackieviruses infection in northern Taiwan--epidemiology and clinical characteristics. Journal of Microbiology, Immunology, and Infection, 42 (1), 38-46. Yin, D., Li, J., Lei, X., Liu, Y. i., Yang, Z., & Chen, K. (2014). Antiviral activity of total flavonoid extracts from Selaginella moellendorffii Hieron against coxsackie virus B3 in vitro and in vivo. Evidence-Based Complementary and Alternative Medicine, 2014. Yu, C., Yan, L., & Wei, Q. (1999). Research proceeding of calcineurin. Chinese Bulletin of Life Sciences, 12 (2), 89-92. Zautner, A. E., Jahn, B., Hammerschmidt, E., Wutzler, P., & Schmidtke, M. (2006). N-and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. Journal of virology, 80 (13), 6629-6636. Zeichhardt, H., Otto, M. J., McKinlay, M. A., Willingmann, P., & Habermehl, K. O. (1987). Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology, 160 (1), 281-285. Zhang, H., Song, Y., & Zhang, Z. (2012). Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice. The American Journal of the Medical Sciences, 344 (3), 206-210. Zhang, W., & Liu, H. T. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research, 12 (1), 9-18. Zhang, Y., Zhu, H., Huang, C., Cui, X., Gao, Y., Huang, Y., Gong, W., Zhao, Y., & Guo, S. (2006). Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-γ. Journal of Cardiovascular Pharmacology, 47 (2), 190-195. Zhu, H., Zhang, Y., Ye, G., Li, Z., Zhou, P., & Huang, C. (2009). In vivo and in vitro antiviral activities of Calycosin-7-O-. BETA.-D-glucopyranoside against coxsackie virus B3. Biological and Pharmaceutical Bulletin, 32 (1), 68-73.
摘要: 腸病毒克沙奇B3型 (coxsackievirus B3, CVB3) 屬於微小核醣核酸病毒科 (Picornaviridae),腸道病毒屬 (enterovirus) 之單股正向RNA病毒。主要感染嬰幼兒及孩童,嚴重時可能引起心肌炎。甘草醇 (glycyrol) 為先前由七葉一枝花 (Paris polyphylla Smith) 分離,抗腸病毒71 型之活性成分,本研究接續探討此化合物對CVB3 KMUH-92225於非洲綠猴腎細胞 (Vero) 之抑制作用及相關作用機轉。 研究結果顯示,甘草醇對CVB3之50%抑制濃度 (50% inhibitory concentration, IC50) 為1.44 ± 0.06 μg/mL,選擇指數 (selectivity index, SI) 為9.94。甘草醇對CVB3之抑制作用包括些微預防病毒感染、輕微抑制病毒吸附宿主細胞及高度抑制病毒之複製;其中,3.00 μg/mL甘草醇能顯著降低CVB3子代病毒效價達0.45-1.42 log PFU/mL;1.50 μg/mL甘草醇亦能有效抑制CVB3於Vero細胞中之VP1表現,為CVB3感染控制組之53%。顯示甘草醇對CVB3 KMUH-92225之抑制,係以抑制病毒複製為主要之作用。甘草醇對CVB3 KMUH-92225之作用機轉之結果顯示,3.00 μg/mL甘草醇顯著抑制感染病毒之宿主細胞IκB⍺降解、細胞核內NF-κB (p65) 及mitogen-activated protein kinase (MAPK) 家族 [p-p38 (phosphate-p38)、p-JNK1/2/3 (phosphate-c-Jun N-terminal kinase 1/2/3) 及p-ERK1/2 (phosphate-extracellular signal-regulated protein kinase 1/2)] 蛋白之活化,因而顯著降低下游細胞發炎物質COX-2之生成。但甘草醇未能影響感染CVB3宿主細胞引起之coxsackievirus and adenovirus receptor (CAR) 內吞作用及Ras GTPase activating protein (RasGAP) 蛋白之降解。 綜合本研究結果,甘草醇對CVB3 KMUH-92225具優異之抑制作用,係透過抑制MAPK及NF-κB路徑之活化,因而降低CVB3於宿主細胞之複製;甘草醇也可藉抑制此兩路徑之活化而有效的減少下游發炎因子COX-2蛋白生成,並減緩宿主細胞嚴重發炎反應,以避免心肌炎產生。
Coxsackievirus B3 (CVB3), a member of the genus Enterovirus, is a positive single-strand RNA virus belonging to the Picornaviridae family. CVB3 mainly infects infants and children, and leads to acute myocarditis. In our previous study, glycyrol was isolated from Paris polyphylla Smith and showed activities of anti-enterovirus 71. This study continued investigating the anti-CVB3 mechanism of glycyrol in Afrian green monkey kidney (Vero) cells. The results showed that glycyrol had an anti-CVB3 activity of glycyrol with 1.44 ± 0.06 μg/mL of 50% inhibitory concentration (IC50). The four mechanisms of inhibiting CVB3 by glycyrol included a little bit prophylactic, slight inhibition of CVB3 adhesion to cells or virucidal, and excellent anti-viral replication effects. Glycyrol (3.00 μg/mL) significantly reduced the CVB3 progeny virus titer of 0.45-1.42 log PFU/mL and the VP1 expression in the CVB3-infected cells, in which the expression was 53% of that in CVB3-infected control. The results showed that glycyrol significantly inhibited the degradation of IκB⍺, the expression of NF-κB (p65), and the activation of mitogen-activated protein kinase (MAPK) (p38, p-JNK1/2/3 and p-ERK1/2) in the CVB3-infected cells. Additionally, COX-2, which is the downstream inflammatory factor, also decreased considerably. However, the endocytosis of coxsackievirus and adenovirus receptor (CAR) and the degradation of Ras GTPase activating protein (RasGAP) caused by CVB3-infection were not affected by glycyrol. In conclusion, possessing the ability to block the MAPK and NF-κB pathways, glycyrol had a great effect on inhibiting CVB3 via reducing the replication in CVB3-infected cells. Moreover, reducing the synthesis of COX-2 by blocking those pathways, glycyrol might have an ability to prevent from myocarditis by reducing inflammation.
URI: http://hdl.handle.net/11455/96037
文章公開時間: 10000-01-01
Appears in Collections:食品暨應用生物科技學系

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.